Literature DB >> 11356117

Phenanthroindolizidine alkaloids as cytotoxic substances in a Danaid butterfly, Ideopsis similis, against human cancer cells.

H Komatsu1, M Watanabe, M Ohyama, T Enya, K Koyama, T Kanazawa, N Kawahara, T Sugimura, K Wakabayashi.   

Abstract

We previously reported the presence of cytotoxic substances in extracts of the Danaid butterfly, Ideopsis similis. In the present study, we isolated cytotoxic substances against a human gastric cancer cell line, TMK-1, in I. similis pupae, with an activity similar to that of the adult butterfly. The basic fraction, prepared from a methanol extract, accounted for 83% of the cytotoxic activity. Two major cytotoxic substances were purified by HPLC, and one was determined to be a new phenanthroindolizidine alkaloid, trans-(+)-3,14alpha-dihydroxy-6,7-dimethoxyphenanthroindolizidine (1), and the other a known compound, trans-(+)-3,14alpha-dihydroxy-4,6,7-trimethoxyphenanthroindolizidine (2). The IC(50) values for TMK-1 cells were 0.5 ng/mL and 0.7 ng/mL, respectively. These two compounds showed similar cytotoxic potential with four other cancer cell lines including cervical, lung, and colon carcinomas and leukemia. Quantitative analyses indicated the presence of each of the two phenanthroindolizidine alkaloids at levels of 11-74 microg in each larva, pupa, or adult of I. similis. However, 1 was not detected in the leaves of Tylophora tanakae, a host plant for larvae of I. similis, and the level of 2 (2 microg per gram of leaves) was far less than that in the larvae. Since the leaves of T. tanakae are known to contain various phenanthroindolizidines, compounds 1 and 2 are presumably metabolically converted from such alkaloids in larvae of I. similis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356117     DOI: 10.1021/jm0004042

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity.

Authors:  Ti Wen; Ziwen Wang; Xianyi Meng; Meng Wu; Yangguang Li; Xiaoli Wu; Liqing Zhao; Puyue Wang; Zhinan Yin; Jesse Li-Ling; Qingmin Wang
Journal:  ACS Med Chem Lett       Date:  2014-07-23       Impact factor: 4.345

2.  Lead Optimization: Synthesis and Biological Evaluation of PBT-1 Derivatives as Novel Antitumor Agents.

Authors:  Lan Xie; Masuo Goto; Xiaoyan Chen; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  ACS Med Chem Lett       Date:  2021-11-17       Impact factor: 4.345

3.  Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-kappaB pathways.

Authors:  Jau-Chen Lin; Shuenn-Chen Yang; Tse-Ming Hong; Sung-Liang Yu; Qian Shi; Linyi Wei; Hsuan-Yu Chen; Pan-Chyr Yang; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

4.  Structural analogs of tylophora alkaloids may not be functional analogs.

Authors:  Wenli Gao; Annie Pei-Chun Chen; Chung-Hang Leung; Elizabeth A Gullen; Alois Fürstner; Qian Shi; Linyi Wei; Kuo-Hsiung Lee; Yung-Chi Cheng
Journal:  Bioorg Med Chem Lett       Date:  2007-11-21       Impact factor: 2.823

5.  Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents.

Authors:  Haining Lv; Jinhong Ren; Shuanggang Ma; Song Xu; Jing Qu; Zhenjia Liu; Qing Zhou; Xiaoguang Chen; Shishan Yu
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

6.  Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus.

Authors:  Cheng-Wei Yang; Yue-Zhi Lee; Iou-Jiun Kang; Dale L Barnard; Jia-Tsrong Jan; Du Lin; Chun-Wei Huang; Teng-Kuang Yeh; Yu-Sheng Chao; Shiow-Ju Lee
Journal:  Antiviral Res       Date:  2010-08-19       Impact factor: 5.970

Review 7.  Possible pharmaceutical applications can be developed from naturally occurring phenanthroindolizidine and phenanthroquinolizidine alkaloids.

Authors:  Xian-Hui Jia; Huan-Xin Zhao; Cheng-Lin Du; Wen-Zhao Tang; Xiao-Jing Wang
Journal:  Phytochem Rev       Date:  2020-09-25       Impact factor: 7.741

8.  The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis.

Authors:  Chi-Yuan Chen; Shuenn-Chen Yang; Kuo-Hsiung Lee; Xiaoming Yang; Lin-Yi Wei; Lu-Ping Chow; Tzu-Chien V Wang; Tse-Ming Hong; Jau-Chen Lin; Crysline Kuan; Pan-Chyr Yang
Journal:  J Med Chem       Date:  2014-01-31       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.